Tools
Stock profile

Elevance Health, Inc. (ELV)

ELV · Latest close $400.84 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$400.84
As of Nov 18, 2026
Tracked funds holding
19 of 149
2026 Q2 13F filings
Opened / added
2 / 6
vs previous quarter
Trimmed / exited
10
vs previous quarter

Elevance Health, Inc. (ELV) is held by 19 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 2 funds opening new positions, 6 funds adding, and 10 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $5.2M sold). Latest close $400.84 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 5, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-5.2M
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Baupost Group · Brave Warrior Advisors · Ruane Cunniff LP — 19 tracked funds hold ELV. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 14 sales ($5.2M). Insider trading

Often held alongside

DOW INC. (DOW) · REINSURANCE GROUP OF AMERICA INC (RGA) · TELEDYNE TECHNOLOGIES INC (TDY) · THOR INDUSTRIES INC (THO) · Haleon plc (HLN) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Baupost Group9.11%1,275,154HELD Q3 filed Nov 13
Brave Warrior Advisors8.23%976,885TRIMMED (-13.0%) Q3 filed Nov 16
Ruane Cunniff LP5.89%979,598TRIMMED (-29.4%) Q3 filed Nov 16
ACR Alpine Capital Research4.05%737,922NEW Q3 filed Nov 2
Veritas Asset Management2.98%428,672TRIMMED (-32.5%) Q3 filed Nov 5
Sound Shore2.90%243,452NEW Q3 filed Nov 6
First Eagle Investment Management2.67%4,188,196ADDED (+1.4%) Q3 filed Nov 10
Oakmark Funds2.53%4,924,511ADDED (+2.7%) Q3 filed Nov 16
Sanders Capital2.26%5,825,024TRIMMED (-1.2%) Q3 filed Nov 2
Century Management2.25%27,514TRIMMED (-2.1%) Q3 filed Nov 16

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +4.3% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

452.69267.542024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

212017Q1: 17 funds2017Q2: 18 funds2017Q3: 17 funds2017Q4: 18 funds2018Q2: 16 funds2018Q4: 16 funds2019Q1: 15 funds2022Q4: 17 funds2023Q1: 18 funds2023Q2: 21 funds2023Q3: 19 funds2023Q4: 20 funds2024Q1: 17 funds2024Q2: 17 funds2024Q3: 16 funds2025Q1: 17 funds2025Q2: 17 funds2025Q3: 18 funds2026Q1: 18 funds2026Q2: 19 funds2017Q12026Q2

Tracked funds holding this stock, by quarter (2017Q1–2026Q2, 20 quarters). Source: quarterly BEST lists from 13F filings — tracked funds only, not all filers. A stock appears here only if it ever made a quarterly BEST list.

All institutions · Form 13F

Institutions holding1,614 of 8,857 filers
Long-only filers among them1,605
Change vs 2026 Q1+162 net · 1,339 entered · 1,177 exited
Shares reported, all filers197,548,936
Reported value, all filers$72.6B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryHospital & Medical Service Plans (SIC 6324)
Revenue · FY2025$199.1B
Net income · FY2025$5.7B
Total assets · FY2025$121.5B
Shares outstanding216,055,891
Market cap (at latest close)$86.6B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 15, 2026.

Short interest

Shares short · Oct 15, 20265,137,559
Share of shares outstanding2.38%
Days to cover4.00

Shares short at recent settlements — Jul 31, 2026: 5.6M · Aug 14, 2026: 5.4M · Aug 31, 2026: 5.5M · Sep 15, 2026: 5.3M · Sep 30, 2026: 4.9M · Oct 15, 2026: 5.1M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 15, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Oct 15, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 14 sales by 2 insiders ($5.2M).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Nov 5, 2026LAVU RATNAKAREVP & Chief Digital Info OfrSell1,300$440.00$572.0KSEC filing
Oct 22, 2026Kaye MarkEVP & CFOSell400$434.00$173.6KSEC filing
Oct 22, 2026Kaye MarkEVP & CFOSell321$435.25$139.7KSEC filing
Oct 22, 2026Kaye MarkEVP & CFOSell1,660$436.20$724.1KSEC filing
Oct 22, 2026Kaye MarkEVP & CFOSell560$437.07$244.8KSEC filing
Oct 22, 2026Kaye MarkEVP & CFOSell240$438.22$105.2KSEC filing
Oct 22, 2026Kaye MarkEVP & CFOSell1,160$439.25$509.5KSEC filing
Oct 22, 2026Kaye MarkEVP & CFOSell1,720$440.44$757.6KSEC filing
Oct 22, 2026Kaye MarkEVP & CFOSell2,343$441.34$1.0MSEC filing
Oct 22, 2026Kaye MarkEVP & CFOSell480$442.61$212.5KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Jul 7, 2026CLARK R KERRYDirector1,500$629.9KJul 7, 2026SEC filing
Jun 12, 2026RONALD WILLIAM PENCZEKOfficer369$148.8KJun 12, 2026SEC filing
Jun 11, 2026Dixon Robert L JRDirector151$60.7KJun 11, 2026SEC filing
May 19, 2026RONALD WILLIAM PENCZEKOfficer1,531$617.2KMay 19, 2026SEC filing
Mar 6, 2026CHARLES MORGAN KENDRICKOfficer3,196$910.6KMar 6, 2026SEC filing
Apr 24, 2025Kaye MarkOfficer4,588$1.9MApr 24, 2025SEC filing
Mar 10, 2025Penczek Ronald WOfficer443$183.9KMar 10, 2025SEC filing
Mar 5, 2025Kendrick Charles Morgan JROfficer3,504$1.4MMar 5, 2025SEC filing
Oct 18, 2024Kendrick Charles Morgan JRDirector7,417$3.2MOct 18, 2024SEC filing
Aug 5, 2024RAMIRO G PERUDirector753$400.2KAug 5, 2024SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Apr 29, 2026Vanguard Capital ManagementSC 13G16,601,2247.1%Mar 31, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
May 7, 2025The Vanguard GroupSC 13G/A22,890,77210.1%Apr 30, 2025SEC filing
Apr 17, 2025BlackRock, Inc.SC 13G/A17,694,6587.8%Mar 31, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Hospital & Medical Service Plans (SIC 6324). Standing committees with jurisdiction over this industry: House Committee on Financial Services, Senate Committee on Banking, Housing, and Urban Affairs.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 398 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Health Issues (371), Medicare/Medicaid (309), Taxation/Internal Revenue Code (192).

Federal contracts: $1.8B in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$244.3M
FY2022$345.1M
FY2023$435.3M
FY2024$186.2M
FY2025$261.1M
FY2026$281.9M

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Insiders

· Opportunistic Buys (Non-Routine) — Last 90 days: 2 or more insiders with no routine buying pattern bought on the open market

Financial Screens

· Growth — Revenue up every year for 5 straight years

· Graham — Sound finances and a long run of profits

· Dividend Growth — Dividends raised for more than 10 years

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Shareholder Yield — Cash returned through dividends and buybacks

· Earnings Stability — Small earnings swings and almost no loss years

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Key figures

· Growth — Latest revenue: $199.1B · 5-yr revenue CAGR: 10.3% · Straight growth years: 15

· Graham — Current ratio: 1.54 · Straight profitable years: 19 · Debt ratio: 1.77 · Latest net income: $5.7B

· Dividend Growth — Dividend per share: 5.92 · Dividend yield: 1.4% · Straight dividend years: 13 · 10-yr dividend growth: 238.3%

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.03 · Operating cash flow: $4.3B · Net income: $5.7B

· Shareholder Yield — Shareholder yield: 4.4% · of which dividends: 1.6% · of which buybacks: 2.8%

· Earnings Stability — Earnings variation (CV): 0.24 · Loss years (of 10): 0 · Latest net income: $5.7B

· Opportunistic Buys (Non-Routine) — Opportunistic buyers: 2 · Buy txns: 3 · Buy value: $1.4M · Latest buy: Jul 17, 2026

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Super-investor 13F BEST — appeared in 20 of the last 40 quarterly lists; latest 2026 Q2, ranked #42 of 50.

· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2025 Q3, ranked #43 of 50.

· Politician BEST — appeared in 4 of the last 20 quarterly lists; latest 2025 Q3, ranked #38 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together1450.0%-0.1%+2.4%-2.5%
Share count tripled (3x)10.0%-2.4%-6.9%+4.4%
Heavy exit — 3+ tracked funds sold out together1100.0%+11.8%+12.1%-0.3%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold ELV — ranked by lift, the co-holding pattern described in Methodology: DOW INC. (DOW) · REINSURANCE GROUP OF AMERICA INC (RGA) · TELEDYNE TECHNOLOGIES INC (TDY) · THOR INDUSTRIES INC (THO) · Haleon plc (HLN) · ABM INDUSTRIES INC /DE/ (ABM) · TRUIST FINANCIAL CORP (TFC) · SS SPDR BB 1-3M T-BILL ETF (BIL).

Recent 8-K filings

FiledItemsSource
Nov 10, 20267.01 Regulation FD DisclosureSEC filing
Oct 21, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Sep 10, 20267.01 Regulation FD DisclosureSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

DOW INC. (DOW) · Track Record: how the signals scored · Practice timing on ELV

One email a week: the week’s new filings and research. Subscribe free

← ELS  ·  ELVN →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.